AllExcel Inc Information

AllExcel has developed as yet unmatched industry leading capabilities in our platform technology that we call "TheraCour?". TheraCour is a micelle forming, self-assembling, polymeric material that has the unique and highly sought-after capabilities: TheraCour can take drugs to specific cancer cells, bacterial cells or virus particles while sparing normal human cells, based on a zip-code-like address based targeting. TheraCour enables tailoring of the pharmaceutical lifetime of a drug, as per the requirement of the specific disease and the intervention. It is possible to achieve short term lifetime of a few hours, a medium lifetime of a couple of days, and even weeks. This enables excellent patient compliance. TheraCour enables tailoring for optimal drug delivery by any route, be it injectable, transdermal, topical ocular, or even oral. This minimizes the formulation stage in drug development. In contrast, liposomal drugs may require years of formulation optimization. TheraCour-based drug candidates have been found to be inherently safe in a multitude of studies against a wide variety of diseases. TheraCour-based drug candidates have demonstrated very high effectiveness in a number of animal models of different diseases. TheraCour enables encapsulation of therapeutic cells so that they can be manufactured, protected in the TheraCour gel, and implanted into a patient while minimizing cell death from host effects, to cure degenerative diseases such as Diabetes, Liver Disease, Cardiac Muscle, Neurodegenration, Parkinson's Disease and more. Our Nanomedicine Technologies Are In Commercialization Phase